Patents by Inventor Peter J. Licari

Peter J. Licari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8618085
    Abstract: Formulations of desoxyepothilones are stable before and after dilution into aqueous media.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: December 31, 2013
    Assignee: Koasn Biosciences Incorporated
    Inventors: Peter J. Licari, Ziyang Zhong, Indu Isaacs, John G. Augustine
  • Patent number: 8030282
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: October 4, 2011
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • Patent number: 7872109
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: January 18, 2011
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • Publication number: 20100227829
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Application
    Filed: April 16, 2010
    Publication date: September 9, 2010
    Applicant: PFIZER INC.
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • Patent number: 7648976
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: January 19, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Peter J. Licari, Timothy Leaf, Ruchir P. Desai, Jorge L. Galazzo, Greg O. Buchanan, Stephen William Watt, Alexander Redvers Eberlin, Robert Arslanian
  • Publication number: 20090042847
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxy-geldanamycin (17-AAG).
    Type: Application
    Filed: May 29, 2008
    Publication date: February 12, 2009
    Applicant: Kosan Biosciences Incorporated
    Inventors: Peter J. Licari, Timothy Leaf, Ruchir P. Desai, Jorge L. Galazzo, Greg O. Buchanan, Stephen William Watt, Alexander Redvers Eberlin, Robert Arslanian
  • Publication number: 20080146654
    Abstract: The invention provides polymorphs of a motilide having a structure represented by formula Ia
    Type: Application
    Filed: December 4, 2007
    Publication date: June 19, 2008
    Inventors: Peter J. Licari, Jorge L. Galazzo, Greg O. Buchanan, Alexander Redvers Eberlin, Mark D. Eddleston
  • Patent number: 7375230
    Abstract: Migrastatin and a migrastatin analog can be produced by fermentation of Streptomyces platensis NRRL 18993 and used in pharmaceutical formulations to treat cancer and/or inhibit metastasis of cancer cells.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: May 20, 2008
    Assignee: Kosan Biosciences, Inc.
    Inventors: Chaitan Khosla, Peter J. Licari, John R. Carney
  • Patent number: 7220560
    Abstract: The present invention provides a generalized oxygen-limited cultivation method for myxobacterial strains engineered to heterologously express polyketides synthase (PKS) gene clusters under various oxygen tension conditions, modulating the polyketide congener distribution.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: May 22, 2007
    Assignee: Kosan Biosciences Incorporated
    Inventors: Peter J. Licari, Bryan Julien, Scott Frykman, Hiroko Tsuruta
  • Publication number: 20040014183
    Abstract: The present invention provides a generalized oxygen-limited cultivation method for myxobacterial strains engineered to heterologously express polyketides synthase (PKS) gene clusters under various oxygen tension conditions, modulating the polyketide congener distribution.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 22, 2004
    Inventors: Peter J. Licari, Bryan Julien, Scott Frykman, Hiroko Tsuruta
  • Publication number: 20030073205
    Abstract: Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.
    Type: Application
    Filed: September 19, 2001
    Publication date: April 17, 2003
    Inventors: Robert L. Arslanian, Gary Ashley, Scott Frykman, Bryan Julien, Leonard Katz, Chaitan Khosla, Janice Lau, Peter J. Licari, Rika Regentin, Daniel Santi, Li Tang